These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 1939532)
1. Type I pseudohypoaldosteronism includes two clinically and genetically distinct entities with either renal or multiple target organ defects. Hanukoglu A J Clin Endocrinol Metab; 1991 Nov; 73(5):936-44. PubMed ID: 1939532 [TBL] [Abstract][Full Text] [Related]
2. Renin-aldosterone response, urinary Na/K ratio and growth in pseudohypoaldosteronism patients with mutations in epithelial sodium channel (ENaC) subunit genes. Hanukoglu A; Edelheit O; Shriki Y; Gizewska M; Dascal N; Hanukoglu I J Steroid Biochem Mol Biol; 2008 Sep; 111(3-5):268-74. PubMed ID: 18634878 [TBL] [Abstract][Full Text] [Related]
3. [Multiple type I pseudohypoaldosteronism: neonatal management and outcome]. Cristina De Frutos Martínez M; Elorza Martínez M; Salas Hernández S; García Sánchez P; Jaso Cortés E; Pérez-Rodríguez J; Quero Jiménez J An Esp Pediatr; 2000 Jan; 52(1):47-51. PubMed ID: 11003859 [TBL] [Abstract][Full Text] [Related]
4. Pseudohypoaldosteronism in eight families: different forms of inheritance are evidence for various genetic defects. Kuhnle U; Nielsen MD; Tietze HU; Schroeter CH; Schlamp D; Bosson D; Knorr D; Armanini D J Clin Endocrinol Metab; 1990 Mar; 70(3):638-41. PubMed ID: 2137831 [TBL] [Abstract][Full Text] [Related]
5. A novel mutation of the epithelial Na+ channel causes type 1 pseudohypoaldosteronism. Bonny O; Knoers N; Monnens L; Rossier BC Pediatr Nephrol; 2002 Oct; 17(10):804-8. PubMed ID: 12376807 [TBL] [Abstract][Full Text] [Related]
6. The enigma of pseudohypoaldosteronism. Zennaro MC; Borensztein P; Soubrier F; Armanini D; Corvol P Steroids; 1994 Feb; 59(2):96-9. PubMed ID: 8191555 [TBL] [Abstract][Full Text] [Related]
7. Erythrocyte transmembrane Na and K fluxes in pseudohypoaldosteronism. Cugini P; Natoli G; Gerlini G; Di Palma L; Rota R; D'Onofrio M; Verna R Biochem Med Metab Biol; 1992 Dec; 48(3):241-54. PubMed ID: 1335741 [TBL] [Abstract][Full Text] [Related]
8. No alteration in the primary structure of the mineralocorticoid receptor in a family with pseudohypoaldosteronism. Zennaro MC; Borensztein P; Jeunemaitre X; Armanini D; Soubrier F J Clin Endocrinol Metab; 1994 Jul; 79(1):32-8. PubMed ID: 8027248 [TBL] [Abstract][Full Text] [Related]
9. The natural history of salt-wasting disorders of adrenal and renal origin. Rösler A J Clin Endocrinol Metab; 1984 Oct; 59(4):689-700. PubMed ID: 6384251 [TBL] [Abstract][Full Text] [Related]
10. Pseudohypoaldosteronism due to renal and multisystem resistance to mineralocorticoids respond differently to carbenoxolone. Hanukoglu A; Joy O; Steinitz M; Rosler A; Hanukoglu I J Steroid Biochem Mol Biol; 1997 Jan; 60(1-2):105-12. PubMed ID: 9182864 [TBL] [Abstract][Full Text] [Related]
11. A novel missense mutation of mineralocorticoid receptor gene in one Japanese family with a renal form of pseudohypoaldosteronism type 1. Tajima T; Kitagawa H; Yokoya S; Tachibana K; Adachi M; Nakae J; Suwa S; Katoh S; Fujieda K J Clin Endocrinol Metab; 2000 Dec; 85(12):4690-4. PubMed ID: 11134129 [TBL] [Abstract][Full Text] [Related]
12. Case report: severe neonatal hyperkalemia due to pseudohypoaldosteronism type 1. Schweiger B; Moriarty MW; Cadnapaphornchai MA Curr Opin Pediatr; 2009 Apr; 21(2):269-71. PubMed ID: 19657313 [TBL] [Abstract][Full Text] [Related]
13. Inactivating mutations of the mineralocorticoid receptor in Type I pseudohypoaldosteronism. Sartorato P; Khaldi Y; Lapeyraque AL; Armanini D; Kuhnle U; Salomon R; Caprio M; Viengchareun S; Lombès M; Zennaro MC Mol Cell Endocrinol; 2004 Mar; 217(1-2):119-25. PubMed ID: 15134810 [TBL] [Abstract][Full Text] [Related]
14. Generalized unresponsiveness to mineralocorticoid hormones: familial recessive pseudohypoaldosteronism due to aldosterone-receptor deficiency. Bosson D; Kuhnle U; Mees N; Ramet J; Vamos E; Vertongen F; Wolter R; Armanini D Acta Endocrinol Suppl (Copenh); 1986; 279():376-80. PubMed ID: 2946135 [TBL] [Abstract][Full Text] [Related]
15. Pseudohypoaldosteronism: family studies to identify asymptomatic carriers by stimulation of the renin-aldosterone system. Kuhnle U; Hinkel GK; Hubl W; Reichelt T Horm Res; 1996; 46(3):124-9. PubMed ID: 8894667 [TBL] [Abstract][Full Text] [Related]
16. Novel mutations in epithelial sodium channel (ENaC) subunit genes and phenotypic expression of multisystem pseudohypoaldosteronism. Edelheit O; Hanukoglu I; Gizewska M; Kandemir N; Tenenbaum-Rakover Y; Yurdakök M; Zajaczek S; Hanukoglu A Clin Endocrinol (Oxf); 2005 May; 62(5):547-53. PubMed ID: 15853823 [TBL] [Abstract][Full Text] [Related]
17. Reduced Na+, K(+)-ATPase activity in patients with pseudohypoaldosteronism. Bistritzer T; Evans S; Cotariu D; Goldberg M; Aladjem M Pediatr Res; 1994 Mar; 35(3):372-5. PubMed ID: 8190530 [TBL] [Abstract][Full Text] [Related]
18. Erythrocyte Na+,K+-ATPase and nasal potential in pseudohypoaldosteronism. Bistritzer T; Kerem E; Berkovitch M; Rapoport MJ; Evans S; Aladjem M Clin Endocrinol (Oxf); 2002 May; 56(5):575-80. PubMed ID: 12030906 [TBL] [Abstract][Full Text] [Related]
19. Identification of a novel mutation in the human mineralocorticoid receptor gene in a german family with autosomal-dominant pseudohypoaldosteronism type 1: further evidence for marked interindividual clinical heterogeneity. Riepe FG; Krone N; Morlot M; Ludwig M; Sippell WG; Partsch CJ J Clin Endocrinol Metab; 2003 Apr; 88(4):1683-6. PubMed ID: 12679457 [TBL] [Abstract][Full Text] [Related]
20. [Mineralocorticoid resistance: pseudohypoaldosteronism type 1]. Fernandes-Rosa FL; Antonini SR Arq Bras Endocrinol Metabol; 2007 Apr; 51(3):373-81. PubMed ID: 17546235 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]